Home › NCT06271707

Stellate Ganglion Block

Left Sided Stellate Ganglion Blocks Impact on the Rate of Post-operative Atrial Fibrillation in Patients Undergoing Thoracic Surgery: A Pilot Study

Who can join

Ages 18 to 85 · All sexes

Inclusion Criteria:

* Patients undergoing esophagectomy, pneumonectomy, or lobectomy aged 18-85.

Exclusion Criteria:

* Patients who have an exclusion to regional anesthesia.
* Patients who have exclusion to stellate blockade.
* Patients who are pregnant assessed via self-report or pregnancy test if they have taken one

About the study

The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.

What is being tested

• 0.5% bupivacaine (drug)
• Saline (other)

Sponsor: University of Minnesota · Participants: 48 · Started: May 19, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06271707

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.